Skip to main content
eScholarship
Open Access Publications from the University of California

UCSF

UC San Francisco Previously Published Works bannerUCSF

Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: A randomized controlled trial

  • Author(s): Herold, KC;
  • Gitelman, SE;
  • Willi, SM;
  • Gottlieb, PA;
  • Waldron-Lynch, F;
  • Devine, L;
  • Sherr, J;
  • Rosenthal, SM;
  • Adi, S;
  • Jalaludin, MY;
  • Michels, AW;
  • Dziura, J;
  • Bluestone, JA
  • et al.
Main Content
For improved accessibility of PDF content, download the file to your device.
Current View